| |NOVEMBER 202419PHARMACEUTICAL INTERMEDIATES MANUFACTURERS - 2024TOP 10Leading the Way in API, Intermediate and Specialty ChemicalsSunmoon Pharmaceuticals' primary focus includes the manufacturing of high-quality pharmaceutical intermediates, which are essential components in the production of active pharmaceutical ingredients. In addition to intermediates, the company specializes in producing specialty chemical compounds, catering to various sectors within the pharmaceutical landscape. This includes offering a wide variety of intermediates that serve as building blocks for different therapeutic applications. The firm prides itself on its ability to provide cost-effective solutions without compromising quality, ensuring that clients receive the best value for their investments. Moreover, the company emphasizes exceptional client service, making themselves available before and after the sale to address any concerns and foster long-term relationships. "As a testament to its growth, Sunmoon Pharmaceuticals has successfully transitioned from manufacturing specialty chemical compounds to producing intermediates and, most recently, APIs in compliance with GMP standards", says Dr. S. K. Upadhyay, Managing Director.Sunmoon Pharmaceuticals is committed to delivering high-quality pharmaceutical products that meet industry standards and fulfill client needs through a robust quality system. The firm conducts thorough evaluations of product documentation, performs rigorous quality-control laboratory tests, and continuously monitors product performance. This meticulous process ensures that they not only meet but exceed client expectations, fostering trust and satisfaction. In addition to its core business, the company is focused on sustainable practices, implementing eco-friendly policies that reduce its environmental impact. The company treats effluents from their manufacturing processes to contribute to a cleaner environment, showcasing their dedication to corporate social responsibility. Its efforts encompass waste reduction, resource conservation, and the use of recycled materials that maintain the same quality as fresh resources. By prioritizing sustainability, the firm emphasizes the efficient use of natural resources, such as water, energy, and raw materials, through resource-efficient practices and the adoption of circular economy principles. This approach safeguards valuable resources during the manufacturing process while ensuring the delivery of premium products to clients. Furthermore, their well-equipped R&D lab and experienced personnel are integral to their success. Sunmoon Pharmaceuticals actively engages in development projects aimed at reducing resource consumption in existing products while adhering to established standards. This commitment to innovation allows them to stay ahead of changing trends in the pharmaceutical ingredients segment, enabling them to offer cutting-edge solutions that meet evolving market demands. Sunmoon Pharmaceuticals has laid out an ambitious future roadmap aimed at expanding its product portfolio and enhancing its global presence. The company plans to increase its offerings of Active Pharmaceutical Ingredients while pursuing globally recognized quality certifications, such as US FDA and EU GMP, to meet international standards. Additionally, the firm intends to establish a state-of-the-art facility dedicated to producing APIs for anticancer medications and develop a world-class formulation unit that complies with global regulations. Ultimately, Sunmoon Pharmaceuticals is focused on scaling its operations internationally, with initial indicators already reflecting progress in this direction. POSunmoon Pharmaceuticals specializes in manufacturing pharmaceutical intermediates, active pharmaceutical ingredients, and specialty chemicals, focusing on quality and sustainability
< Page 9 | Page 11 >